Researchers at the University of Toronto’s Department of Chemical Engineering & Applied Chemistry have made a groundbreaking advancement in the sustainable production of medium-chain fatty acids (MCFAs), unlocking potential pathways to replace ecologically harmful palm oil with bacterial fermentation methods. This discovery, published in the esteemed journal Nature Microbiology, delves into the metabolic intricacies of certain anaerobic bacteria and how they can be harnessed to create commercially valuable chemicals through fermentation processes that recycle organic waste.
Medium-chain fatty acids, encompassing molecules with carbon chains ranging from six to twelve atoms, are integral to numerous industries, from cosmetics and agriculture to nutritional supplements and antimicrobial formulations. Valued at approximately three billion dollars globally, these fatty acids are currently derived predominantly from palm kernel oil. However, the environmental impact of palm oil production—marked by widespread deforestation, loss of biodiversity, and difficulty in ensuring sustainably sourced feedstocks—has spurred researchers to explore more eco-friendly alternatives.
Professor Chris Lawson, leading this pioneering research, emphasizes the importance of developing cleaner sources of MCFAs. Unlike genetically engineered microbes such as E. coli or yeast, which require refined sugars and entail costly processing, Lawson’s team focuses on naturally occurring chain-elongating bacteria (CEBs). These anaerobic bacteria thrive in oxygen-deprived environments and excel in fermenting complex organic waste to produce fatty acid chains, minimizing the need for agricultural inputs and enabling waste valorization.
Notably, these bacteria collaborate within microbial consortia to decompose organic substrates, converting food waste and agricultural byproducts, including dairy residues and municipal organic waste streams, into valuable medium-chain fatty acids. This approach promises a circular bioeconomy model where waste feedstocks are efficiently upcycled into marketable, high-value chemicals. Yet, one significant challenge persisted: the production yield often skewed towards shorter, lower-value molecules like butyrate (four carbons) instead of the desired octanoic acid (eight carbons).
The crux of this issue lies in the internal metabolic regulation of CEBs, which until now remained elusive. Lawson’s team deployed comprehensive metabolic and biochemical analyses revealing that the product spectrum depends critically on the ratio of lactate to acetate consumed by the bacteria. This newly elucidated mechanism illustrates how manipulating substrate conditions can steer the bacterial fermentation pathway towards producing longer and higher-value fatty acids.
Central to these findings is the enzyme CoA transferase (CoAT), which facilitates the formation of fatty acid chains. The researchers identified a distinct variant of CoAT in CEBs capable of processing intermediates six and eight carbons long, in stark contrast to the enzymes in bacteria limited to producing butyrate. This difference underpins the natural ability of some bacterial strains to generate higher-value MCFAs, offering a molecular handle to enhance production through microbial engineering or process optimization.
Armed with this molecular insight, the research team is now poised to design fermentation systems tailored to maximize octanoic acid yields. Moving beyond laboratory studies, they are scaling their bioprocess design towards industrial application, integrating bioreactors optimized for high-density bacterial cultures and efficient product recovery. Efforts led by graduate students and collaborators aim to bridge the gap between promising bench-scale results and commercial viability.
Parallel to metabolic studies, Lawson’s group has pioneered genetic tools enabling the manipulation of CEB genomes. These tools open avenues for bioengineering efforts to extend fatty acid chain lengths even further, reaching into the nine-to-twelve carbon atom range, thus broadening the potential product portfolio. Such enhancements could revolutionize the marketplace, providing sustainable alternatives to petrochemical-derived surfactants and specialty chemicals.
The team’s dedication also manifests through entrepreneurial ambitions. Founders of the startup SymBL Innovations, composed of three team members, are now advancing commercialization of their microbial technology. Backed by recent grants from Genome Canada and Ontario Genomics, their startup exemplifies translation of academic discovery into market-ready sustainable products, catalyzing industry shifts towards ethical sourcing and waste valorization.
Crucially, this initiative is part of a larger multidisciplinary alliance—the Waste to Chemicals (W2C) collaboration—that combines academic, industrial, and consortium efforts across Ontario. Supported by the Ontario Water Consortium, NSERC, and Mitacs, this partnership underlines the systemic shift towards integrating biotechnological solutions to global sustainability challenges, from waste management to green chemistry.
Professor Lawson underscores that industrial-scale implementation demands proving consistent, cost-competitive production of MCFAs in bioreactor processes, a milestone that will cement the viability of this bio-based platform. The sustainability narrative is not just a marketing advantage but a central pillar as consumer and regulatory demand for ethically sourced ingredients intensifies worldwide.
This landmark discovery at the University of Toronto thus represents a multifaceted breakthrough: elucidating bacterial metabolic pathways, engineering novel enzymes, developing scalable bioprocesses, and linking research endeavors directly to innovative commercialization. It exemplifies how harnessing microbial metabolism can circumvent the ecological toll of traditional chemical feedstocks, pointing to a future where waste transforms into wealth in green chemical industries.
Subject of Research: Sustainable production of medium-chain fatty acids (MCFAs) via bacterial fermentation
Article Title: Understanding and Optimizing Bacterial Fermentation Pathways for Medium-Chain Fatty Acid Production
News Publication Date: 2024
Web References:
- Nature Microbiology article
- SymBL Innovations
- Genome Canada and Ontario Genomics award
- Waste to Chemicals Alliance
References:
Chris Lawson et al., “Metabolic and enzymatic determinants of medium-chain fatty acid production in chain-elongating bacteria,” Nature Microbiology, 2024. DOI: 10.1038/s41564-026-02320-8
Image Credits: Photo by University of Toronto Engineering
Keywords
Medium-chain fatty acids, bacterial fermentation, chain-elongating bacteria, CoA transferase, octanoic acid, sustainable chemistry, green bioprocessing, metabolic modeling, waste valorization, microbial engineering, industrial biotechnology, bioreactor scale-up
